scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11695-007-9056-8 |
P698 | PubMed publication ID | 17546836 |
P50 | author | Magnus Sundbom | Q45747963 |
P2093 | author name string | Camilla Holdstock | |
F Anders Karlsson | |||
Britt Eden Engström | |||
P2860 | cites work | Diagnosis of gastritis by means of a combination of serological analyses | Q78025767 |
The effects of gastric surgery on systemic ghrelin levels in the morbidly obese | Q80332487 | ||
Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy | Q81781892 | ||
Nutritional implications of cephalic phase gastrointestinal responses | Q33879627 | ||
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery | Q33959262 | ||
The Abdominal Distribution of the Vagus. | Q34075233 | ||
Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity | Q34330489 | ||
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin | Q34513044 | ||
Roles of pancreatic polypeptide in regulation of food intake | Q34515739 | ||
Accuracy of screening for gastric cancer using serum pepsinogen concentrations | Q35355212 | ||
Vagal, cholinergic regulation of pancreatic polypeptide secretion | Q37052243 | ||
Pancreatic polypeptide: a hormone under vagal control. | Q40091735 | ||
Serum gastrin, insulin and somatostatin levels in normal and obese subjects before and after gastric banding | Q42030707 | ||
Gastric and cephalic stimulation of human pancreatic polypeptide release | Q42095153 | ||
Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans | Q42169738 | ||
A safe and noninvasive test for vagal integrity revisited | Q44082149 | ||
The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats | Q44165158 | ||
Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects | Q44392867 | ||
Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. | Q44548921 | ||
Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms | Q44708051 | ||
Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians | Q44779252 | ||
Acetylcholine regulates ghrelin secretion in humans | Q44883293 | ||
The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans | Q45050687 | ||
Effects of modified sham feeding on ghrelin levels in healthy human subjects | Q45096642 | ||
Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release | Q46509736 | ||
The stomach speaks--ghrelin and weight regulation | Q47185232 | ||
Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass | Q47189295 | ||
Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia | Q47401795 | ||
Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. | Q50875385 | ||
Investigation of the excluded stomach after Roux-en-Y gastric bypass. | Q64902211 | ||
Role of thought, sight, smell, and taste of food in the cephalic phase of gastric acid secretion in humans | Q69990108 | ||
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer | Q69995603 | ||
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia | Q70370598 | ||
Serum pepsinogen in screening for gastric cancer | Q71722453 | ||
Reduction in serum pepsinogen I after Roux-en-Y gastric bypass | Q73429522 | ||
Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection | Q73978409 | ||
Fundus functionality and ghrelin concentrations after bariatric surgery | Q75265071 | ||
Serum antibodies to H+,K+-ATPase, serum pepsinogen A and Helicobacter pylori in relation to gastric mucosa morphology in patients with low or low-normal concentrations of serum cobalamins | Q77689088 | ||
P433 | issue | 3 | |
P304 | page(s) | 304-310 | |
P577 | publication date | 2007-03-01 | |
P1433 | published in | Obesity Surgery | Q15762541 |
P1476 | title | Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? | |
P478 | volume | 17 |
Q34404065 | Altered ghrelin secretion in mice in response to diet-induced obesity and Roux-en-Y gastric bypass |
Q36533912 | Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery |
Q35677192 | Bariatric surgery for extreme adolescent obesity: indications, outcomes, and physiologic effects on the gut-brain axis |
Q36970993 | Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice |
Q39076089 | Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study |
Q37812028 | Changes in Ghrelin Levels Following Bariatric Surgery: Review of the Literature |
Q44621765 | Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects |
Q34824005 | Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review |
Q34824270 | Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery |
Q30391329 | Changes in neurohormonal gut peptides following bariatric surgery |
Q36479829 | Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms |
Q37740010 | Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity |
Q34589770 | Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? |
Q26851369 | Development of minimally invasive techniques for management of medically-complicated obesity |
Q37471710 | Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans |
Q35579577 | Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels. |
Q36986145 | Effects of gastrogastric fistula repair on weight loss and gut hormone levels |
Q48141578 | Gastric bypass surgery elevates NT-ProBNP levels |
Q35581251 | Gastrointestinal hormones and bariatric surgery-induced weight loss |
Q26995199 | Ghrelin and eating disorders |
Q34026487 | Ghrelin and metabolic surgery |
Q38018268 | Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds |
Q47253610 | Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. |
Q33804394 | Helicobacter pylori infection and circulating ghrelin levels - a systematic review |
Q47273553 | Influence of additional resection of the gastric fundus on excessive weight loss in laparoscopic very very long limb Roux-en-Y gastric bypass |
Q81545124 | Is a pouch compulsory in Roux-en-Y gastric bypass after failed adjustable gastric banding? |
Q37949475 | Lessons learned from gastric bypass operations in rats. |
Q51352550 | Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. |
Q26780440 | Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review |
Q35529693 | Mechanisms responsible for excess weight loss after bariatric surgery |
Q90680826 | Metabolic and Endocrine Consequences of Bariatric Surgery |
Q30252857 | Metabolic responses to exogenous ghrelin in obesity and early after Roux-en-Y gastric bypass in humans |
Q37922651 | Metabolic surgery-principles and current concepts |
Q35054892 | Obesity surgery and gut-brain communication |
Q37511828 | Obesity, gut hormones, and bariatric surgery. |
Q35204654 | Peripheral mechanisms in appetite regulation |
Q46364996 | Postprandial changes in gut regulatory peptides in gastric bypass patients |
Q41625381 | Potential Hormone Mechanisms of Bariatric Surgery. |
Q41893226 | Robotic-assisted gastroplication in a morbidly obese adolescent: early improvement in metabolic and neurohormonal parameters |
Q51320902 | Roux-en Y gastric bypass is superior to duodeno-jejunal bypass in improving glycaemic control in Zucker diabetic fatty rats. |
Q33879265 | Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding |
Q42730636 | The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective |
Q26783535 | The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones |
Q37691662 | The effect of bariatric surgery on gut hormones that alter appetite |
Q37095586 | The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones |
Q89064954 | The effects of bariatric surgical procedures on the improvement of metabolic syndrome in morbidly obese patients: Comparison of laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass |
Q35535513 | The gut sensor as regulator of body weight |
Q30388925 | The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity |
Q81786442 | Vagal nerve dissection during pouch formation in laparoscopic Roux-Y-gastric bypass for technical simplification: does it matter? |
Q84371773 | [Metabolic surgery] |
Search more.